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Abstract 
 
Background: Antifungal multidrug resistance has been reported worldwide and has stimulated investigations of plant 
species for the treatment of candidiasis. In particular, in vitro antifungal activities and cytotoxicity of dry extracts from 
Ceasalpinia ferrea (tul.) Martius, Brosimum acutifolium Huber, and Salacia impressifolia (Miers) A.C. Smith were 
evaluated.  
Materials and Methods: Minimum inhibitory concentrations (MIC) and minimum fungicide (MFC) values were 
established according to the protocol M27-A2 of the Clinical and Laboratory Standards Institute (CLSI). Subsequent 
evaluations were performed using strains of Candida albicans from the American Type Culture Collection (ATCC) 
10231, clinical isolated Candida albicans, Candida glabrata (CCT) 0728, Candida krusei (FTI) CCT 1517, and 
Candida guilliermondii (CCT) 1890. Morphological changes were evaluated using scanning electron microscopy 
(SEM), and cytotoxicity was evaluated in murine L929 fibroblast cells after treatment with plant extracts.  
Results: MIC values indicated antifungal potential of all three extracts against the main fungi that causes candidiasis.  
Conclusion: In particular, C. ferrea showed promising antimicrobial potential against all strains. Hence, future studies 
are warranted to investigate pharmacologically active compounds from this extract that could be used as prototypes for 
drug development and/or as a source of raw pharmaceutical materials for the treatment of candidiasis. 
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Introduction 
 
Candidiasis is one of the most prevalent and important fungal infections of the oral cavity and is caused by 
various Candida species, particularly Candida albicans. However, 50% of these infections are caused by non-albicans 
species, such as Candida tropicalis, Candida parapsilosis, Candida glabrata, Candida guilliermondii, and Candida 
krusei (Forastiero et al., 2015).  Bensadoun, Patton, Lalla and Epstein (2011) described oropharyngeal candidiasis as 
the principal cause of morbidity in patients with malignancies in hospitals, and if not treated correctly, these infections 
can reach the bloodstream and the urinary tract. Moreover, these infections have been observed in surgical sites, 
producing challenging conditions for tertiary care globally. The incidence of candidemia in Brazilian public hospitals is 
about 2.5 cases per 1,000 admissions (Colombo et al., 2013), and is considered the most common manifestation of 
invasive candidiasis. However, more than 30% of blood cultures are negative, and Candida species are almost never 
considered contagious (Kauffmam, 2016). Nonetheless, candidiasis is considered a significant public health problem in 
underdeveloped areas, and a dangerous infection in developing countries (Nucci et al., 2013). 
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Pharmacological treatments for Candida spp. infections include polyenics, azoles, and their derivatives 
(Mangueira, Mangueira and Melo Diniz, 2010). However, these agents lack specificity for Candida species and their 
efficacy varies between fungal species, hosts, and therapies (Arendrup, 2013). In addition, microorganisms of the 
Candida genus have generated resistance to a variety of antifungal drugs, leading to poor treatment effects and 
increasing disease severity. Hence, studies of new pharmacologically active compounds for the treatment of fungal 
conditions are warranted (Morais-Braga et al., 2016). 
Innovations of natural product research remain scarce in developing countries. However, numbers of studies of 
plant species have increased exponentially in recent decades, and many of these have been translated into novel 
technologies and prospective treatments (Simonetti et al., 2016). Although the herbal medicines market accounts for 
less than 5% of all marketed medicines (Dutra et al. 2016), Brazil has considerable potential for the “green market,” 
which follows an average annual growth of around 8%–25%, well above the 4% increase in marketing of synthetic 
products (Febrafarma, 2007). Hence, increase in the global demand for green medicinal products and natural therapies, 
with fewer adverse effects is comparable to that of synthetic compounds in existing formulations (Dutra et al., 2016). 
Brazilian biodiversity is considered the largest in the world, and is distributed in biomes including the 
Amazon, Caatinga, Pantanal, Cerrado, Pampas and Atlantic Forest (Araújo et al., 2014; Instituto Brasileiro de 
Geografia e Estatística [IBGE], 2016). Many plant species from brazilian biomes are used as traditional medicines and 
many have demonstrated antimicrobial (Kuete et al., 2011;  Oliveira et al.; 2015; Akca et al., 2016) and antifungal 
properties (Mollashahi et al., 2015; Aghasadeh et al., 2016). Among these, Salacia impressifolia (Miers) A.C. Smith is 
popularly known as miraruíra (Smithsonian Institution, 2015), and salacia species present antidiabetic (Ripardo Filho 
et al., 2016), antimicrobial, antifungal, and antioxidant activities (Martins et al., 2016), and hepatoprotective, cytotoxic, 
anti-inflammatory, antiobesity, hypotensive, and antiulcerogenic effects (Prata, 2007), warranting their use in 
traditional medicines and as phyto-medications. In addition, the Brazilian specie Caesalpinia ferrea tul. Martius is 
popularly referred to as ironwood or jucá, and pharmacological applications of shells, seeds, roots, and fruits from this 
species are traditionally used to heal wounds and bruises (Oliveira et al., 2014a). Accordingly, anti-inflammatory 
(Oliveira et al., 2014b), antifungal (Bariani et al., 2012), antihistaminic, antiallergic, anticoagulant, and larvicidal 
activities (Cavalheiro et al., 2009), and antiproliferative, cytoprotective, and antimutagenic effects have been shown 
(Silva et al., 2015). More, Brosimum acutifolium huber, a genus widely known in the amazon under various 
denominations (mururé, congona, mapuré-pagé, moruré) (Lima, Silva and Veiga-Júnior, 2013), stands out as a 
traditional medicine, with anti-inflammatory activities of its barks, roots, and stems, and efficacy in the treatment of 
rheumatism, muscular and bone pain, and as a diuretic, anti-allergic, immunomodulatory, antioxidant, provascular, 
antitumor, and antimicrobial agent (Lima, Silva and Veiga-Júnior, 2013). 
Herein, we evaluated antifungal activities of dried extracts of Salacia impressifolia (Miers) A.C. Smith, 
Caesalpinia ferrea tul. Martius, and Brosimum acutifolium Huber against the predominant strains of the genus 
Candida, and the effect on the viability of mouse L929 fibroblast cells. 
 
Materials and Methods  
Plant Species 
 
Peels of Brosimum acutifolium Huber, Salacia impressifolia (Miers) A.C. Smith, and seeds of Caesalpinia 
ferrea (Tul.) Martius were acquired at the “Ver-O-Peso” market in Belem, Pará, Brazil (Latitude 01270210 0S and 
Longitude 48300160 OW). Extracts were obtained by macerating 25-g specimens of specified plant parts in 70% (v/v) 
ethanol for 72 h in the dark. Extracts were filtered under low pressure (Rotavapor® R-210, Buchi, Switzerland), 
lyophilized (ALPHA 1-4 ID plus, Christ, Germany) under 1.8-mBar pressure at −14°C, and then maintained at room 
temperature in the dark, until use in in vitro assays. 
 
Fungal species 
 
Microbiological analyses were performed using standard C. albicans, American Type Culture Collection 
(ATCC) 10231; C. glabrata (Taniwaki, M.H.), Collection of Tropical Cultures (CCT) 0728; C. krusei, (FTI) CCT 
1517; C. guilliermondii (CCT), 1890 from the Foundation André Tosello (Campinas, São Paulo, Brazil); and C. 
albicans from clinical specimens, which were a gift from the Laboratory Murilo Baldi of the academicals hospital of 
the Federal University of Juiz de Fora, Minas Gerais, Brazil. 
 
Antifungal activity 
 
MIC and MFC values were established according to the protocol M27-A2 of the Clinical and Laboratory 
Standards Institute [CLSI] (2002). Briefly, fungal suspensions were obtained from respective strains using sterile saline 
solution 0.9 % (v/v) after 48 h of growth at 35 ± 2°C. Densities of suspensions were adjusted to 89%–90% 
transmittance in a spectrophotometer (Multiskan GO Microplate Spectrophotometer, Toronto, Ontario, Canadá) at 530 
nm. Samples were then diluted in buffered Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma Aldrich 
Chemistry, Burlington, Massachusetts, USA) with 3(N-morpholino) propanesulfonic (MOPS) (JTBaker®, Phillipsburg, 
NJ, USA) to obtain 5–25 × 102 CFU and pH was adjusted to 7.0 ± 0.1 using 0.5-M sodium hydroxide. 
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Assays were performed in triplicate and plant extracts were diluted to 4.8–5,000 µg/mL in RPMI-1640 
medium containing MOPS buffer and 2 µl of 70% (v/v) ethanol solution. 
Sterile polypropylene microplates with 96 wells and level depths were purchased from Sarstedt AG and Co 
(Germany), and 100-µL aliquots of respective dilutions of vegetable extracts were added with 100 µL aliquots of 
standardized fungal suspensions. Control wells contained 100 µL of the same inoculated culture medium containing 2 
µL of 70% ethanol and 98 µL of RPMI 1640 medium containing MOPS. The negative control contained 200 µL of 
medium. Amphotericin B (Cristália, Cristal Pharma, Contagem, MG, Brazil) and nystatin (Cavalieri handling 
Pharmacy, Juiz de Fora, MG, Brazil) were used as reference drugs at 0.0313–16.0 µg/mL. 
After inoculation, microplates were incubated at 35 ± 2°C for 48 h, and MIC values were established as the 
lowest concentration in which no fungal growth was observed. MFC values were determined using the microdilution 
method. Briefly, 10-µL aliquots were withdrawn from wells in which no growth was observed in the MIC procedure, 
were transferred to new wells containing 1 mL of Sabouraud dextrose broth (SDB), and were incubated at 35 ± 2°C for 
48 h. Subsequently, concentrations with no fungal growth were classified as MFC values. 
 
Scanning electron microscopy 
 
Samples for SEM analyses were prepared from untreated fungal colonies (negative control) and from colonies 
exposed to reference drugs or dried extracts. Fungal suspensions were standardized at 89%–90% transmittance using a 
spectrophotometer at a fixed wavelength of 530 nm. All samples, containing dried extracts or reference drugs were 
diluted to their respective MIC values in MOPS buffered RPMI 1640 medium. Subsequently, fungal suspensions 
containing test-substances were added to microplates and were incubated at 35 ± 2°C for 48 h. Samples were then 
washed in 0.1-M phosphate buffer, were centrifuged at 1,301 × g, and were fixed to glass cover slips with 2.5% (v/v) 
glutaraldehyde solution. Samples were then stored for 12 h at 8°C prior to dehydration using an ethanol sequence of 
50%, 70%, 90%, and then 100% over 15 min. Dehydrated samples were then adhered to coverslips using poli-d-lisina 
(Sigma®), were fixed in aluminum stubs that were metallized with a thin layer of gold (Balzers FL-9496/Furstentum 
Liechtenstein), and were analyzed using SEM with a JSM-5310, JEOL instrument at 25-Kv power and a working 
distance of 17 mm. All electromicrographs were captured in the Center for Scanning Electron Microscopy at the 
Museum National of the University Federal of Rio de Janeiro (UFRJ). 
 
Evaluation of cellular viability using MTT assays 
 
Cell viability of L929 fibroblasts was evaluated after culture in DMEM (Nutricell®, Campinas, SP, Brazil) 
supplemented with 10% fetal bovine serum (SFB) (Invitrogen, CA, USA), 100-U/mL penicillin, 100-U/mL 
streptomycin, and 10-mM (4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid buffer (HEPES) (Mosmann, 1983). 
Cells were cultured in sterile 96-well plates with level depths (Sarstedt, Germany) at a density of 5 × 103 cells/well and 
were then incubated in an oven at 37 ± 2ºC in an atmosphere containing 5% CO2 for 48 h. Subsequently, culture media 
were replaced with sample solutions (reference drugs or dry extracts) at concentrations of 7.81–1,000 µg/mL. Plates 
were then incubated at 37 ± 2ºC in an atmosphere containing 5% CO2 for 48 h. Controls were not inoculated and 
contained 2 µl of 70% (v/v) ethanol. After 48 h, culture media were removed and 100-µL aliquots of 10% [3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] (MTT; 5 mg/mL) in DMEM were added to all wells. Plates 
were immediately incubated at 37 ± 2ºC in an atmosphere containing 5 % CO2 for 3 h. Finally, the resulting formazan 
crystals were dissolved in DMSO and absorbance was evaluated using a spectrophotometer (Multiskan GO, Thermo 
Scientific, USA) at 540 nm (Twentyman and Luscombe, 1987). 
 
Statistical analysis 
 
Data are expressed as means ± standard errors of the mean (SEM) and are representative of five replicates. 
Differences were identified using analyses of variance (ANOVA) followed by Bonferroni’s test (Graphpad Prism 
versão 6 e IBM SPSS Statistics 21) and were considered significant when p < 0.05. 
 
Results and Discussion 
Antifungal activity 
 
Dry extracts were tested in the range of 4.8–5,000 µg/mL, and antifungal actions against the standard C. 
albicans strain (MIC = 9.7 µg/mL) were observed for C. ferrea (MFC = 1,250 µg/mL) and S. impressifolia (MFC = 
2,500 µg/mL). Regarding non-albicans species, fungistatic actions of C. ferrea were observed against all strains with 
MIC values of 19 µg/mL for C. glabrata, 78 µg/mL for C. krusei, and 4.8 µg/mL for C. guilliermondii. Despite 
fungicidal the actions of S. impressifolia against all non-albicans strains, MFC values were considered high (2,500–
5,000 µg/mL). MIC and MFC values are summarized in Table 1. 
According to the classifications of antifungal activity employed  by  Simonetti et al. (2016) extracts with MIC < 
100 µg/mL are considered promising antimicrobials, whereas those with MIC values of 100–500, 500–1,000, and 
>1,000 µg/mL are considered moderate, weak, and inactive against pathogens, respectively. Accordingly, the species S. 
impressifolia presented moderate activity against clinically isolated C. albicans (MIC, 312 µg/mL). Furthermore, dry 
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extracts of C. ferrea showed promising antimicrobial potential against all albicans and non-albicans species. For 
Mendes et al. (2011) there is no consensus on the level of acceptable inhibition by plant extracts when compared with 
reference drugs, likely reflecting general differences in antimicrobial actions of drugs between distinct microbial 
cultures (Kuete et al.,  2011). 
 
 
The widely used pharmacological treatments nystatin and fluconazole are still recommended as the first line of 
therapy for candidiasis (Mangueira, Mangueira and Melo Diniz, 2010). However, these agents are merely fungistatic 
against candida spp. (Bensadoun et al., 2011; Arendrup, 2013). Hence, the antifungal multiresistance that has been 
reported in several countries, especially for non-albicans species, has led scientists to determine patterns of 
susceptibility of this pathogen to conventional antifungal agents with the purpose of ensuring the most effective 
therapeutic strategy (Kuete et al., 2011; Bensadoun et al.,  2011; Arendrup, 2013; Morais-Braga et al., 2016). 
Furthermore, natural products have been evaluated alone or in combination with other drugs in the search for 
new components that can neutralize mechanisms of resistance in yeasts of the genus Candida (Morais-Braga et al., 
2016). 
S. impressifolia has varied botanical distribution and contains various secondary metabolites of interest (Prata, 
2007; Ripardo-Filho et al., 2016; ). However, no previous reports demonstrate antifungal activities of S. impressifolia 
against various Candida strains. In contrast, antifungal activities of fruits, stem, and leaves of Caesalpinia species are 
widely disseminated in the literature (Freitas, 2012; Araújo et al., 2014; Oliveira et al., 2014a;  Silva, 2015), although 
few studies have reported antifungal activities of dry C. ferrea seed extracts (Cavalheiro et al., 2009; Bariani et al., 
2012).  
Possible fungicidal actions of trypsin inhibitors in the seeds of this leguminous plant against phytopathogenic 
fungi show promising actions against natural fungicide, leading to decreased mycelial growth and sporulation (Bariani 
et al., 2012). In contrast, aqueous extracts of C. ferrea seeds did not inhibit the growth of Aspergillus niger, Fusarium 
oxysporum, Fusarium solani, Fusarium pallidoroseym, Mucor sp., Neurospora sp., Penicillium herguei, or Phomopsis 
sp. (Cavalheiro et al., 2009). 
Scientific evidence of the actions of C. ferrea remain deficient, warranting studies of therapeutic effects at the 
cellular level, and studies of parts of the plant with specific activities (Oliveira et al. 2014a; Silva et al. 2015). Herein, 
we show that the effects of B. acutifolium against candida strains were similar to those described previously (Oliveira 
et al., 2015). In particular, antifungal activities of crude extracts from this plant species against C. albicans and C. 
krusei in disc diffusion tests led to average inhibition halos of 9.0 and 7.0, respectively, although no inhibition of C. 
tropicalis was observed (Brito-Costa et al. 2013). Previously, crude extracts of this species had an average MIC value 
of 64 µg/mL in 50% of studied microbial species, with a MIC of 32 µg/mL against the standard C. albicans strain 
(Kuete et al. 2011). 
 
Scanning electron microscopy (SEM)  
 
The electromicrographs (Figure 1) showed morphological changes that were compatible with decreases and loss 
of viability of fungal cells after exposure to extracts of S. impressifolia, C. ferrea, B. acutifolium, and the reference 
drugs nystatin and amphotericin B. Exposures to these extracts and drugs caused similar changes in all yeasts, and 
resulted in dehydrated and compacted appearances of fungal cells. In particular, cell compression and adhesion, cell 
growth were frequently observed, and shear zones or fissures and areas of structural deformation with overflow of 
cellular material caused loss of the original morphology. These changes likely reflect cell membrane permeability to 
these drugs (Bensadoun et al., 2011; Arendrup, 2013).  
Several authors suggest that the presence of triterpenes, catechins, sterols, and tannins in shells of S. 
impressifolia confer potential therapeutic actions (Ripardo Filho et. al., 2016; Martins, Caneschi, Vieira,  Barbosa and 
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Raposo, 2016). Similarly, the presence of catechins (Araújo et al., 2014), terpenoids (Ximenes, 2009), polyphenols, 
hydroxy-phenols, or methoxylated compounds (Pereira et al., 2016)  in C. ferrea  may confer analgesic, anti-
inflammatory, and antibiotic effects of the ensuing extracts.  
 
Figure 1: Electromyrographies of Candida albicans American Type Culture Collection (ATCC) 10231 (A), 
Candida glabrata (Taniwaki , M.H.) CCT 0728 (B), Candida guilliermondii CCT 1890 (C) and Candida  
krusei (FTI) CCT 1517 (D). Yeasts not exposed to pharmacological treatments (1); exposed to nystatin (2); 
to anphotericin B (3); to Salacia impressifo lia Miers Smith (4); to Caesalpinia ferrea (Tul) Martius (5) and
Brosimum acutifolium Huber  (6) evidencing cell compression and adhesion in (A2;B2;B5;B6;D2 and D3); 
shear  zones or fissures of hyphae (White index: A5; C6) and areas of structural deformation (White index: 
B3;D4;D5) with extravasation of cellular  material (White index: C4;C5). Magnification: 5000x. Scale bar: 
5µm.  
 
 
Alternatively, ethanolic extracts of C. ferrea fruits contain tannins and phenols that can promote hemolysis by 
oxidizing hemoglobin (Almeida, Lima e Silva, Amorim, Maia and Albuquerque, 2005). Moreover, legume seeds are 
abundant in protein (10% overall), and the ensuing agglutination or precipitation of glycoconjugates reportedly leads to 
inhibition of cell growth and mitochondrial respiration (Ximenes, 2009; Bariani et al., 2012). Proteolytic enzymes from 
c. ferrea string bean lectins can also inhibit c. albicans growth, and have antifungal potential (Ximenes, 2009).  
Other studies indicate that alkaloid and flavonoid phytoconstituents in B. acutifolium species are responsible 
for antifungal activity. Reported activities of these phytochemicals include blockade of free radical chain reactions, 
which donate oxygen atoms and cause cell lysis (Moraes, 2011; Kuete et al., 2011; Lima, Silva and Veiga-Júnior., 
2013; Fonseca, 2014; Oliveira, 2015). Anti-inflammatory activities of this plant species were also shown using the 
isolated bas1 flavonoid (4'-hydroxy, 7, 8 - (2'', 2''-dimethyl-pyran)-flavan) (Moraes, 2011). 
 
Evaluation of cellular viability using MTT assays 
 
The toxicity of dry extracts on the viability of mouse L929 fibroblast cells were investigated using MTT 
assays (Figure 2). These data revealed significant differences (p < 0.05) among the control (Dulbecco's Modified Eagle 
Medium - DMEM) and treatments with three plant species, with 80% inhibition of cell viability in the presence of 
higher concentrations (1,000; 500, and 250 µg/mL). However, at concentrations of 7.81–125 µg/mL, no cytotoxic 
effects were observed.  
According to Zieger (2007), lower required concentrations of extracts from plant species with cytotoxic and/or 
cytoprotective actions correspond with greater potential for the treatment of humans.  
In the present study, C. ferrea, B. acutifolium and S. impressifolia extracts did not  present  cytotoxic effects 
(cell viability, 110.92%), at concentrations bellow of 250 µg/mL and/or 125 µg/mL . In agreement, Moraes (2011) 
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showed cytotoxic effects of B. acutifolium extracts only at high concentrations (100 µM) in cell viability assay 
evaluated by the MTT in stimulated murine macrophages. 
In the work of Oliveira and Marreiro (2014), the C. ferrea sheath hydroalcoholic extract present in a 
formulation of the mouthwash, in vitro citotoxicity assay,  showed only 8% cell viability against murine fibroblasts. In 
another study, low cytotoxicity of bioactive lectins from C. ferrea sheath hydroalcoholic extracts was demonstrated in 
tumor cells, suggesting biological activities and safety of these extracts (Freitas, 2012). Moreover, the crude extract of 
the seeds of C. ferrea did not show acute toxicity in mice, even when administered at the maximum dose (0.3 mL/10 g 
body weight) (Cavalheiro et al., 2009). Numerous studies with plant species show its efficacy as a source of new drugs 
with therapeutic applications. In general, the indiscriminate use of plant preparations and products of unknown 
composition lead to health risks in the absence of rigid standards (Araújo et al., 2014; Oliveira et al., 2015). 
 
 
 Therefore, further studies of natural products with greater pharmacological activities, lower toxicity and lower 
production costs will lead to discoveries of new bioactive molecules, since few of them have been rigorously validated 
so far (Morais-Braga et al., 2016). 
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Conclusion 
 
In conclusion, the present data demonstrate antifungal activities of three plant extracts. C. ferrea demonstrated 
the most promising antimicrobial potential against all C. albicans and non-albicans strains. Moreover, the 
electromicrographs demonstrated significant structural deformations in all strains tested. At concentrations of 7.81–125 
µg/mL, C. ferrea extract did not affect cell viability of L929 fibroblasts. These results indicate antifungal potential 
against the main fungi that causes oropharyngeal candidiasis, and warrant future studies of pharmacologically active 
compounds. Future studies may lead to consideration of these plant materials as prototypes for drug development 
and/or as sources of pharmaceutical raw materials for the treatment of candidiasis. 
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